SARS-CoV-2 Infection Clinical Trials

390 clinical trials for SARS-CoV-2 Infection across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 — RECRUITING · NA
• Cardiovascular Assessment 5 Years After MIS-C — RECRUITING
• COVID-19 Transmission and Morbidity in Malawi — RECRUITING
• Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 — RECRUITING · NA
• Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID — RECRUITING · PHASE3
• C4671026-A PHASE 2/3, INTERVENTIONAL SAFETY, PHARMACOKINETICS, AND EFFICACY, OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332 (NIRMATRELVIR)/RITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID-19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE — RECRUITING · PHASE3
• Exercise in Child Health — RECRUITING · NA
• T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients — RECRUITING · PHASE1
• Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS — RECRUITING · PHASE2
• Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India — RECRUITING
• A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses — RECRUITING · PHASE1
• Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients — RECRUITING · PHASE2
• SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study — RECRUITING
• Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection — RECRUITING
• SARS-CoV-2 in Air (COVID-19) — RECRUITING
• A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19 — COMPLETED · PHASE3
• Clinical Validation of the NowFuture Digital Flu / COVID Test in Anterior Nasal Samples for Over-the-Counter (OTC) Use in Australia — NOT_YET_RECRUITING · NA
• Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19 — COMPLETED · NA
• Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome — ACTIVE_NOT_RECRUITING · NA
• Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections — NOT_YET_RECRUITING
• The ACDC Study Assessing Cognitive Deterioration in COVID-19 — COMPLETED
• Safety and Immunogenicity of NVX-CoV2705 — COMPLETED · PHASE3
• CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2 — ACTIVE_NOT_RECRUITING
• Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States — COMPLETED · PHASE4
• A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years — COMPLETED · PHASE3
• NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19 — ACTIVE_NOT_RECRUITING
• Transplacental Transmission of RSV (TTRSV) — ACTIVE_NOT_RECRUITING
• Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample — COMPLETED · NA
• Efficacy and Safety of NVX-CoV2705 — ACTIVE_NOT_RECRUITING · PHASE4
• Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 — TERMINATED · PHASE3
• CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools — ACTIVE_NOT_RECRUITING
• A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals — COMPLETED · PHASE2
• COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study — ACTIVE_NOT_RECRUITING · PHASE1
• Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol — COMPLETED
• Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern — COMPLETED · PHASE2
• Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults — COMPLETED · PHASE3
• Pancoronavirus Vaccine Study in Healthy Adults — ACTIVE_NOT_RECRUITING · PHASE1
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — ACTIVE_NOT_RECRUITING · PHASE3
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — COMPLETED · PHASE2
• Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age. — COMPLETED · PHASE2
• PET/CT Imaging in COVID-19 Patients — COMPLETED · PHASE1
• Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva — COMPLETED
• COVID-19 on Placental Gene Expression and Pathology — COMPLETED
• Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test — NOT_YET_RECRUITING · NA
• COVIDOM+: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease – consequences for health status and quality of life — OTHER
• An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. — COMPLETED · PHASE4
• Safety and Tolerability of COVID-19 Vaccine (ABNCoV2) — COMPLETED · PHASE1
• Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda — COMPLETED · PHASE2
• The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection — COMPLETED · PHASE4
• Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults — COMPLETED · PHASE1

Refine this search